Jacob R J, Dziura J, Blumberg M, Morgen J P, Sherwin R S
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8020, USA.
Diabetes. 1999 Jan;48(1):141-5. doi: 10.2337/diabetes.48.1.141.
To determine whether antecedent recurrent hypoglycemia protects the brain from the adverse effects of a standardized hypoglycemic stimulus, we implanted electrodes in the inferior colliculi of diabetic rats to directly record inferior colliculi auditory-evoked potentials (ICEPs). Awake, chronically catheterized BB rats were studied after 2 weeks of insulin therapy designed to produce either chronic hyperglycemia (hyper-DM, glycated hemoglobin 7.6 +/- 0.4%) or recurrent hypoglycemia (hypo-DM, glycated hemoglobin 6.2 +/- 0.7%), and the results were compared with those observed in nondiabetic rats. When plasma glucose was lowered to and clamped at 2.8 mmol/l, the release of catecholamines was suppressed in the hypo-DM rats (epinephrine: 2.5 +/- 0.4 nmol/l) as compared with hyper-DM and the nondiabetic rats (9.3 +/- 2.3 and 32.7 +/- 6.1 nmol/l, respectively). ICEP latency was significantly delayed in hyper-DM and nondiabetic rats (P < 0.001), but it was unchanged in hypo-DM rats. A more pronounced reduction in plasma glucose (2.0 mmol/l), however, provoked a greater adrenergic response than that seen at 2.8 mmol/l and delayed ICEP latency by 23% in a separate group of hypo-DM animals. These data demonstrate that antecedent recurrent hypoglycemia attenuates the brainstem dysfunction associated with mild to moderate, but not severe, hypoglycemia in diabetic rats. This phenomenon may contribute to the alterations in hypoglycemia counterregulation seen in diabetic patients during intensive insulin therapy.
为了确定先前反复发生的低血糖是否能保护大脑免受标准化低血糖刺激的不利影响,我们将电极植入糖尿病大鼠的下丘,以直接记录下丘听觉诱发电位(ICEPs)。在接受旨在产生慢性高血糖(高血糖糖尿病组,糖化血红蛋白7.6±0.4%)或反复低血糖(低血糖糖尿病组,糖化血红蛋白6.2±0.7%)的胰岛素治疗2周后,对清醒、长期插管的BB大鼠进行研究,并将结果与非糖尿病大鼠的结果进行比较。当血浆葡萄糖降至并钳制在2.8 mmol/L时,与高血糖糖尿病组和非糖尿病大鼠(分别为9.3±2.3和32.7±6.1 nmol/L)相比,低血糖糖尿病组大鼠的儿茶酚胺释放受到抑制(肾上腺素:2.5±0.4 nmol/L)。高血糖糖尿病组和非糖尿病大鼠的ICEP潜伏期显著延迟(P<0.001),但低血糖糖尿病组大鼠的ICEP潜伏期未发生变化。然而,在另一组低血糖糖尿病动物中,更显著的血糖降低(2.0 mmol/L)引起了比2.8 mmol/L时更大的肾上腺素能反应,并使ICEP潜伏期延迟了23%。这些数据表明,先前反复发生的低血糖可减轻糖尿病大鼠与轻度至中度而非重度低血糖相关的脑干功能障碍。这种现象可能导致糖尿病患者在强化胰岛素治疗期间低血糖反调节的改变。